Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC2648 Icpd62
Novel inhibitor of heat shock protein 90 (Hsp90), demonstrating anticancer activity against colorectal, osteosarcoma and cervical cancer cell lines
More description
DCC2647 Icl-sirt078
Novel highly selective, substrate-competitive SIRT2 inhibitor, displaying a significant neuroprotective effect in a lactacystin-induced model of Parkinsonian neuronal cell death in the N27 cell line
More description
DCC2646 Icl-ccic-0019
Novel potent and selective inhibitor of choline kinase alpha (CHKA)
More description
DCC2645 Iclaprim
Novel selective bacterial dihydrofolate inhibitor, antibiotic, actively against Gram positive organisms
More description
DCC2644 Ici-56780
Antimalarial agent, displaying blood schizonticidal activity against P.berghei
More description
DCC2643 Ici-185282
Potent thromboxane receptor antagonist
More description
DCC2642 icec0943
Novel selective inhibitor of CDK7
More description
DCC2641 Ical-36
Novel inhibitor of CALP, exhibiting affinity of 22.6 ± 8.0 μM for CALP and no interaction with the NHERF PDZ domains
More description
DCC2640 Icagen-4
Inhibitor of voltage-gated K(+) (Kv) channels Kv1.3 and Kv1.5
More description
DCC2639 ica-27243
Neuronal Kv7 potassium channel activator
More description
DCC2638 Ic2418
MmpL3 inhibitor, being active against drug-resistant Mycobacterium tuberculosis
More description
DCC2637 Ibs399024
Novel HDAC6-selective inhibitor
More description
DCC2636 Ibrutinib-bfl
Novel fluorescent irreversible inhibitor of Bruton's tyrosine kinase (BTK)
More description
DCC2635 Ibpr002
Novel Aurora kinase inhibitor, revealing mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules
More description
DCC2634 Ibpr001 Hydrochloride
Novel Aurora kinase inhibitor
More description
DCC2633 Ibl-302
First-in-class triple-acting PIM/PI3K/mTOR inhibitor, demonstrating single-agent, anti-tumour efficacy in suppression of pAKT, pmTOR and pBAD in the SKBR-3, BT-474 and HCC-1954 HER2+/PIK3CA-mutated cell lines
More description
DCC2632 Ibe-667
Novel activator of LFA-1-ICAM-1 binding
More description
DCC2631 Iaxo-101
Novel inhibitor of the cluster of differentiation 14 innate immunity pathway
More description
DCC2630 Iap-in-1
Novel antagonist of IAP (inhibitor of apoptosis protein)
More description
DCC2629 Ianthelliformisamine C Tfa Salt
Antibiotic enhancer against resistant Gram-negative bacteria
More description
DCC2628 Ianthelliformisamine B Tfa Salt
Antibiotic enhancer against resistant Gram-negative bacteria
More description
DCC2627 Ianthelliformisamine A Tfa Salt
Antibiotic enhancer against resistant Gram-negative bacteria
More description
DCC2626 Ianthellamide A
Selective kynurenine-3-hydroxylase inhibitor
More description
DCC2625 Iag-10
Novel potent and selective inhibitor of human DNA polymerase kappa (hpol κ)
More description
DCC2624 Hz-ma Hybrid 11b
Novel potent and selective inhibitor of fat mass obesity-associated protein (FTO), being selectively over alkylation repair homologue 5 (ALKBH5), another DNA/RNA demethylase
More description
DCC2623 Hys-32
Novel analogue of combretastatin A-4, enhancing connexin43 expression
More description
DCC2622 Hymenidin
Natural antagonist of serotonergic receptors and inhibitor of CDK5/p25 and GSK-3ß
More description
DCC2621 Hydroxytriolein
Novel anticancer agent, inhibiting lung cancer cell proliferation via a PKCa and ERK1/2 dependent mechanism
More description
DCC2620 Hydroxymatairesinol
Natural antioxidant and anti-cancer agent, blocking the MAPK/NF-κB and activating Nrf2/HO-1
More description
DCC2619 Hydroxyellipticine-1a
Novel selective r(CGG)exp probe, improving pre-mRNA splicing defects, inhibiting formation of nuclear inclusions and RANT in a FXTAS cellular model
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X